Lirum Therapeutics

United Kingdom
Newyork, Argyll and Bute, United Kingdom

Company profile

Lirum Therapeutics company profile

Lirum Therapeutics is a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases by acquiring, developing, and commercialising novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$7M
Last funding
Series Unknown / $7M / 2023-02-08
Last equity funding
Series Unknown / $7M
Articles
39

Founders and investors

No public relation records are available.